MedTrace Logo

Dexamethasone Versus Magnesium Sulphate as an Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Plane Block for Postoperative Analgesia in Elective Caesarean Section Under Spinal Anesthesia

NCT07139522 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2025-08-24

No results posted yet for this study

Summary

This study aims to compare the efficacy of adding dexamethasone and magnesium sulfate as an adjuvant to bupivacaine in bilateral erector spinae block in postoperative pain control in patients undergoing caesarean section under spinal anesthesia.

Conditions

  • Dexamethasone
  • Magnesium Sulphate
  • Adjuvant
  • Ultrasound
  • Erector Spinae Plane Block
  • Postoperative Analgesia
  • Cesarean Section
  • Spinal Anesthesia

Interventions

DRUG

Bupivacaine

Patients will receive 20 ml of 0.25% isobaric bupivacaine.

DRUG

Dexamethasone

Patients will receive 20 ml of (0.25% isobaric bupivacaine and 4mg of dexamethasone).

DRUG

Magnesium sulphate

Patients will receive 20 ml of (0.25% isobaric bupivacaine and 200mg of magnesium sulphate).

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2025-12-01
Completion
2025-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07139522 on ClinicalTrials.gov